Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) Sees Significant Decline in Short Interest

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) was the recipient of a large decrease in short interest during the month of July. As of July 31st, there was short interest totaling 4 shares, a decrease of 96.2% from the July 15th total of 106 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are sold short.

Ambu A/S Stock Performance

Shares of Ambu A/S stock remained flat at $10.86 during trading on Tuesday. Ambu A/S has a twelve month low of $8.54 and a twelve month high of $16.78. The business has a 50-day simple moving average of $10.04 and a two-hundred day simple moving average of $10.87. The company has a quick ratio of 1.73, a current ratio of 2.92 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $2.55 billion, a PE ratio of 38.79 and a beta of 0.93.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.